MyofascialPainSyndromeTreatments

Myofascial pain syndrome (MPS) is a common and challenging musculoskeletal condition characterized by painful trigger points in skeletal muscle that can significantly impact patients' quality of life. Despite affecting an estimated 21-30% of patients in general medical clinics and up to 85-90% in specialized pain clinics, MPS often remains underrecognized and undertreated. The condition causes focal pain with characteristic referral patterns, can be associated with autonomic dysfunction, and may lead to functional impairment, mood disturbances, and sleep problems over time.

The authors conducted a comprehensive narrative review of current evidence-based treatments for myofascial pain syndrome. They systematically examined the literature on both pharmacological and non-pharmacological interventions, including patient education, exercise therapy, manual techniques, physical modalities, dry needling, trigger point injections, and botulinum toxin. The review evaluated the effectiveness, mechanisms of action, and clinical applications of each treatment approach, providing practical guidance for clinicians managing patients with MPS.

The review revealed that effective MPS treatment requires a multimodal approach targeting both the trigger points themselves and the underlying factors that perpetuate them. Exercise and patient education emerged as foundational treatments for all patients, with stretching being particularly important to lengthen shortened muscle bands. Pharmacological options showed variable evidence, with topical NSAIDs, muscle relaxants like cyclobenzaprine and tizanidine, and certain antidepressants showing promise. Dry needling and trigger point injections were found to be effective for persistent trigger points, with no clear superiority of one needling technique over another.

Physical modalities like ultrasound, TENS, and massage showed modest benefits. Botulinum toxin showed mixed results and may be reserved for refractory cases.

This comprehensive review provides clinicians with evidence-based guidance for treating myofascial pain syndrome using a systematic, multimodal approach. The emphasis on exercise and education as foundational treatments is particularly important, as these interventions address the underlying muscle dysfunction rather than just providing temporary symptom relief. The finding that no single needling technique is clearly superior allows clinicians to choose methods they are most comfortable and experienced with, while the mixed evidence for botulinum toxin suggests it should be reserved for difficult cases. Most importantly, the review emphasizes that successful MPS treatment requires addressing not just the trigger points themselves, but also the biomechanical, postural, psychological, and lifestyle factors that contribute to their development and persistence.